Principles of Signal Transduction: Objectives
1. Be able to compare and contrast the overall properties of endocrine and synaptic signaling mechanisms.
- Endocrine Signaling Mechanism:
- Hormone is secreted by an endocrine gland and is carried, via the bloodstream, to a distant target cell
- Signaling is SLOW
- Relies on passive diffusion and blood flow
- Signals are DILUTE
- Receptors have high specificity and affinity for the signal
- Chemically based specificity and affinity
- There is a slow termination of the response (slow dissociation rate)
- Endocrine cells secrete many ligands – thus the target cells must be specific with a high affinity
- Example: Steroids
- Synaptic Signaling Mechanism:
- Signaling is FAST
- Uses electrical impulses over short distance
- Signals reach high local concentrations
- Receptors have low affinity for the signal
- Mechanically based (based on the placement of the synapses)
- There is a rapid termination of the response (quick dissociation rate)
- Secrete few distinct ligands – the specificity comes from the precise nerve/target cell contact point
- Examples: Peptides and proteins; catecholamines
2. Be able to identify the four major types of signal transduction pathways and give examples of ligands and cellular responses for each.
- Receptor Tyrosine Kinase
- Ligands: Insulin, lots of growth factors
- Insulin Receptor Signaling:
- Receptor binds two signal compounds (in this case, insulin peptide) which activates a tyrosine autokinase. This also phosphorylates IRS-1 (“Insulin Receptor Substrate 1”).
- IRS-1 has three tissue specific pathways
- Growth: IRS1 phosphorylates Shp, activating Ras.
- Ras activates MAP which activates Transcription factors which promote growth
- Glucose Uptake
- IRS-1 phosphorylates P13K, initiating a phosphorylation cascade
- Leads to GLUT4 (transporters of glucose) onto the plasma membrane
- Glycogen Deposistion
- IRS1 phosphorylates P13K, initiating a phosporylation cascade
- Leads to stimulation of enzymatic steps in the conversion of glucose to glycogen
- G Protein-Linked Receptors
- Ligands: a great variety use G Protein-Linked Receptors
- Catecholamines, NTs, Peptide hormones…
- 2 possible cellular responses:
- cAMP Signal Pathway
- cAMP activates cAMP-dependent Protein Kinase (PKA) by phosphorylating PKA
- Kinase is a tetramer
- 2 cAMP-binding chains
- 2 catalytic chains
- Binding causes release of activated catalytic subunits
- Catalytic units phosphorylate substrates (usually enzymes)
- Moderation or reversal of response is achieved via:
- Dephosphorylation of substrates
- By phosphatases
- Degradation of cAMP
- By phosphodiesterases (PDE)
- Phosphatidylinositol Pathway
- Hormone signal causes increase in cytosolic Ca++ and activation of PKC, leading to 2 distinct (but interacting) chain of events:
- Ca++ binds to Calmodulin (CaM)
- Myosin Light Chain Kinase (MLCK) phosphorylates myosin
- Causes interaction with actin and muscle contracts
- Nitric Oxide Synthase (NOS)
- Protein Kinase C phosphorylates a variety of enzymes and proteins
- Ion channels (like Na+/H+ pump)
- Phosphorylation leads to increase of cellular pH and proliferation
- Activation of transcription factors controlling gene expression
- Intracellular Receptors (steroids)
- Examples of ligands: Glucocorticoid, mineralcorticoid, progesterone, estrogen, androgen, vitamin D, thyroid
- Three domains
- Transcription activation Domain
- Responsible for interaction promoting activity by RNA polymerase
- Thus, Communication with Pol
- DNA Binding Domain
- Site of direct interaction with DNA in the promoter region of genes
- Thus, Recognition of Hormone Response Elements
- Ligand Binding Domain.
- Site of high-selectivity binding by steroid hormones
- Thus, Binding Site
- 2 Activated Steroid Receptors recruit the Histone Acetyl Transferase (HAT) Complex
- Leading to acetylation of histones
- Causes DNA to unwind
- Allowing the binding of the transcription apparatus.
- Ligand Gated Channels
- Converts extracellular signals into electrical impulses
- Occurs between nerves and target cells (“Chemical Synapse”)
- Nerve terminal releases neurotransmitters (Ach, GABA, etc…) by fusion with storage vesicles with plasma membrane
- NT binds channels present in synapse region of target cell
- Gated channel opens, allowing entry of ions
- Example: Nicotinic Acetylchnoline Receptor:
- Channel opening requires 2 molecules of ligand
- Channel opens only briefly
- Closes while still ligated
- Ligand dissociates, returning channel to resting state
- Dissociated ACh is hydrolyzed by cholineresterase
3. Be able to identify or describe the key steps and molecules involved in each of the four major pathways, including structure and location of receptors, 2nd messenger molecules (including calcium and nitric oxide), effector enzymes, and substrates.
- Ligand-Gated Channels
- Key Steps:
- Nerve terminal releases neurotransmitters
- Via fusion of storage vesicles with plasma membrane
- NT binds channels present in synapse region
- Gated channel opens, allowing entry of ions
- Molecules involved:
- Neurotransmitters
- ACh, GABA, Serotonin, Glutamate, Glycine…
- Structure of receptors:
- Composed of 5 transmembrane polypeptides
- Each chain ~500 AAs and traverses membrane four (4) times
- 1 helix of each chain contains polar AAs: “Aqueous Pore”
- Negatively-charged AAs are at the mouth of the channel
- Prevents entry of anions (ligand specificity)
- Location of receptors:
- Plasma membrane of Target Cells (transmembrane)
- 2nd messenger molecules:
- Effector Enzymes:
- Cholineresterase (hydrolyzes dissociated ACh)
- Substrates:
- Receptor Tyrosine Kinases:
- Key Steps:
- Ligand binding to the insulin receptor (IR)
- Induces phosphorylation on tyrosine residues on the intracellular domain
- 2 ligands of insulin peptide are required for full activation
- Molecules involved:
- Insulin Peptide
- IRS1
- Ras (for MAP kinase cascade to promote growth factors)
- P13K (is phosphorylated by IRS1, initiates phosphorylation cascade)
- Structure of receptors:
- Single transmembrane alpha helix
- Example: Insulin
- 2 beta and 2 alpha chains (sulfide bond connects them)
- Alpha chains: contain hormone-binding site
- Beta chains: traverse the membrane and contain tyrosine kinase domain
- Location of receptors:
- On the plasma membrane (transmembrane)
- Extracellular domain
- Ligand-binding site
- Intracellular domain
- Tyrosine kinase activity
- 2nd messenger molecules:
- IRS1
- Ras(for MAP kinase cascade to promote growth factors)
- P13K (is phosphorylated by IRS1, initiates phosphorylation cascade)
- Effector Enzymes:
- MAP Kinase (activates transcription factors to promote growth)
- Substrates:
- Steroid (Intercellular) Receptors:
- Key Steps:
- 2 Ligand-ed Steroid Receptors recruits a co-activator that contains the enzyme, “Histone Acetyl Transferase” (HAT)
- That enzyme leads to acetylation of histones
- The acetylated histones allow the DNA to unwind
- The unwound DNA allows for the binding of general transcription factors (such as Pol II)
- Molecules involved:
- SR (Steroid Receptor)
- HSP
- IP
- CoA Complex
- TATA (gene expression begins here via RNA transcription)
- Structure of receptors:
- NH2 – Transcription activation domain – DNA binding domain – Ligand binding domain – COOH
- Receptors are always “ON”
- Location of receptors:
- Plasma membrane
- Cytosol
- Nucleus
- 2nd messenger molecules:
- Effector Enzymes:
- Histone Acetyl Transferase (HAT)
- Acetylates histones
- Leads to the unwinding of DNA
- Allows for binding of general transcription factors
- Substrates:
- G-Protein Linked Receptors
- Structure of receptors:
- “7 Pass” transmembrane receptor
- Generates 4 intracellular and extracellular loops
- Extracellular amino terminus:
- Ligand binding site
- Intracellular loops:
- G Protein Interaction
- Phosphorylation-mediated inactivation
- When 3rd loop is phosphorylated, the receptor is inactivated
- cAMP Signaling:
- Key Steps:
- Hormone stimulateion causes rapid increase in cAMP
- Adenylate cyclase cleaves ATP to generate cAMP and pyrophosphate
- IRREVERSIBLE step
- Degradation of cAMP by phosphodiesterase
- Yields 5’-AMP
- Molecules involved:
- cAMP, PKA (cAMP-dependent protein kinase)
- Location of receptors:
- On Plasma membrane
- Alpha chain:
- Binds and hydrolyzes GTP
- Activates adenylate cyclase
- Beta and Gamma chains:
- Anchors alpha chain to the cytoplasmic face
- 2nd messenger molecules:
- Cyclic AMP (cAMP)
- Effector Enzymes:
- Adenylate cyclase cleaves ATP to generate cAMP and pyrophosphate
- IRREVERSIBLE step
- Degradation of cAMP by phosphodiesterase
- Yields 5’-AMP
- Substrates:
- Ca++/Phosphoinositide Signal Pathway:
- Key Steps:
- Molecules involved:
- Cam (Calmodulin)
- Location of receptors:
- Plasma membrane
- On they cytosolic face
- 2nd messenger molecules:
- Diacylglycerol (DAG)
- Inositol Trisphosphate (IP3)
- Ca++ Ion
- Effector Enzymes:
- MLCK (phosphorylates myosin, causing muscle contraction)
- Nitric Oxide Synthase (NOS)
- Protein Kinase C (phosphorylates lots of enzymes and proteins)
- Substrates:
4. Be able to describe the major mechanisms by which each signal pathways can be inhibited.
- Tyrosine Kinase, Steroid, and Ligand-Gated Channels:
- Down-regulation of Cell Surface Receptors
- Prolonged hormone exposure leads to receptor degradation
- G-Linked
- Inactivation of receptors via phosphorylation:
1. Excess hormone
- Results in receptor that can bind hormone but not activate G protein
- Phosphorylation of serines and threonines on intracellular loops
- A-kinase first to phosphorylate when cAMP levels get too high, followed by BARK
- Fully phosphorylated receptor is further blocked from G protein by beta arrestin